fepblue glp 1 2025 GLP-1 RA prescription trends: January 2019 – December GLP-1 Shortage = Over -

*Fatal myocardial infarction

For example, slower transit can shift nutrient availability in the colon, potentially favoring certain bacterial strains over others

Dont assume its already in the computer or that weight-loss shots arent important

The weight loss industry has been extremely commercialized, and there are a lot of snake oil salesmen out there

Tirzepatide has received approval for use in patients with T2D following several phase 3 studies testing and demonstrating its marked anti-hyperglycemic efficacy and positive actions on multiple cardiovascular risk factors, associated with an excellent safety profile [2, 3]